image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k |
|---|---|---|
5bb86068fa044128a025db6922fd083ec33a4017495b156bebce383993d9667b.png | simple | <table><tr><td>Particle</td><td>Loading capacity (%)</td><td>Loading efficiency (%)</td><td>Size (nm)</td><td>Administration route</td><td>In vitro/in vivo results</td><td>Ref.</td></tr><tr><td>NLCs (glyceryl tridecanoate, glyceryl tripalmitate, soy lecithin and Kolliphor HS15, and chitosan)</td><td>3</td><td>99</td><t... |
dab64efa2d5d74cb05a674909181ed876baa8baf86738648459fcf8af7efe7c1.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="2">Adherence</td><td rowspan="2">OR (95% CI)</td><td rowspan="2">p-value</td></tr><tr><td>Yes [n,(%)]</td><td>No [n,(%)]</td></tr><tr><td>Perceived benefits of DM drugs</td><td></td><td></td><td></td><td></td></tr><tr><td>A lot of benefits</td><td>251 (85.9)</td><td>... |
ea056cba5bab12c0d233b476723405c72f6e88a34c2a3c1276565e88edd6efa1.png | complex | <table><tr><td>Model</td><td>Unstandardized Coefficients <i>B</i></td><td>Unstandardized Coefficients <i>SE</i></td><td>Standardized Coefficient <i>ß</i></td><td><i>t</i></td><td><i>p</i></td></tr><tr><td colspan="6">A. Results of the linear Regression for Variables Predicting PTSD Symptoms</td></tr><tr><td> Const... |
6e56fcac80ae20bcf9c50d9ddb55da4a8994ee66a3acfe651d88a269f046b155.png | simple | <table><tr><td>Phenotype</td><td>SNP</td><td>Chromosome</td><td>Position (bp)a</td><td>Alleleb</td><td>MAFc (%) in cases</td><td>MAFc (%) in controls</td><td>RRd (95% CI)</td><td><i>P</i> value</td><td>Nearby genee</td></tr><tr><td>BE</td><td>rs3072</td><td>2p24</td><td>20,741,887</td><td>G/A</td><td>38.1</td><td>37.0<... |
18794042706e5487ef6e391bc5233ded5701e247ed2d8b0fd02f940d9b91d140.png | simple | <table><tr><td>Characteristic</td><td>Rotavirus Diarrhea (n = 71)</td><td>Nonrotavirus Diarrhea (n = 149)</td><td><i>P</i> Value</td></tr><tr><td>Age, mo<sup>a</sup></td><td>9 (3–27)</td><td>10 (2–30)</td><td>.335</td></tr><tr><td>Male sex</td><td>42 (59.2)</td><td>78 (52.3)</td><td>.422</td></tr><tr><td>Pr... |
082dc3b7cfed1863d88b55421f223a10f0a02a82ba59b419eb12f4f6329edcce.png | simple | <table><tr><td>Author</td><td>Age</td><td>Symptoms</td><td>Site of tumor</td><td>Histology</td><td>Treatment</td><td>Relapse(months)</td><td>Treatment of relapse</td></tr><tr><td>Our case</td><td>56</td><td>Urinary symptomsLower abdominal distention</td><td>Corpus</td><td>IT</td><td>Hysterectomy</td><td>Yes (3)</td><td... |
ee83663a219587c26faae1496362e8f086f771b6b4033e69ccf512333432e378.png | simple | <table><tr><td>n</td><td></td><td>1108</td></tr><tr><td>Age (yrs)</td><td>Median</td><td>61.5</td></tr><tr><td></td><td>Range</td><td>40.2-79</td></tr><tr><td>PSA (ng/ml)</td><td>Median</td><td>6.99</td></tr><tr><td></td><td>Range</td><td>0.3-20</td></tr><tr><td>Pathological Stage</td><td>pT2</td><td>770 (69.6%)</td></... |
ae9806d081d6c1a515e0ac9059c31c96cfd7b800fbcdcede0c57f136a8b97d23.png | complex | <table><tr><td></td><td>Expected</td><td colspan="2">Jinan</td><td colspan="2">Xuzhou</td><td colspan="2">Hefei</td><td colspan="2">Shanghai 2000</td><td colspan="2">Shanghai 1986</td></tr><tr><td>Centile</td><td>(%)</td><td>Boys</td><td>Girls</td><td>Boys</td><td>Girls</td><td>Boys</td><td>Girls</td><td>Boys</td><td>G... |
8b1eedc61b7a77c4d8f8f84bb6aa091d745023b86a56a00e72eb594aa1bed506.png | complex | <table><tr><td></td><td colspan="2">Non smokersn = 19</td><td colspan="2">Ex-smokersn = 6</td><td colspan="2">Current smokersn = 14</td></tr><tr><td>Males (n, %)</td><td>7</td><td>36,8</td><td>6</td><td>100</td><td>11</td><td>78,6</td></tr><tr><td>Age, years; mean+SD</td><td>46,6</td><td>4</td><td>46</td><td>4,5</td><t... |
cfdde3ff3c0e533c8c349cc406146151c0dca69c12206d9f76db7b90ec03973b.png | complex | <table><tr><td rowspan="2">Parameter</td><td rowspan="2">Unit</td><td colspan="3">Tier within the breeding program</td></tr><tr><td>Nucleus</td><td>Multiplier</td><td>Commercial</td></tr><tr><td>Flock breeding ewes</td><td>Head</td><td>826</td><td>7000</td><td>180,000</td></tr><tr><td>Flock breeding rams</td><td>Head</... |
0084e2d895ff11c95eb967f66bb3a0bf80b780cc08cdf18e263155361da5f048.png | complex | <table><tr><td></td><td></td><td colspan="3">Direct</td><td colspan="3">Indirect</td></tr><tr><td>IC1</td><td><i>n</i></td><td>2.5</td><td>50</td><td>97.5</td><td>2.5</td><td>50</td><td>97.5</td></tr><tr><td>Eire</td><td>1949</td><td>0.1</td><td>0.2</td><td>0.2</td><td>0.0</td><td>0.0</td><td>0.1</td></tr><tr><td>Great... |
cbd0561839dc5bae697016af8ebb908cdd7fba57a5f9d7dbb30edde3f6d068dd.png | simple | <table><tr><td></td><td></td><td></td><td></td><td>Cluster</td><td></td><td></td></tr><tr><td></td><td></td><td>Professional</td><td>Consumer</td><td>Organizational</td><td>Financial</td><td>Regulatory</td></tr><tr><td></td><td>Breast</td><td>4</td><td>9</td><td>4</td><td>0</td><td>0</td></tr><tr><td></td><td>Gastroint... |
777437292bb9275519ee53d2572f7b08ce5e4145aeb5a8b6644cc3bb7157af46.png | simple | <table><tr><td></td><td>Laparoscopic cholecystectomy(n = 120)</td><td>Small-incision cholecystectomy(n = 137)</td><td>Statistical analysis</td></tr><tr><td>Mortality</td><td>0</td><td>0</td><td></td></tr><tr><td>Complications</td><td>21</td><td>16</td><td>p = 0.119</td></tr><tr><td>intra-operative</td><td>5</td><td>3</... |
45eeafe47335ce78a008486fb520ef90ef47e1ac3cf7fab6ddfa78d2f7d3206d.png | complex | <table><tr><td rowspan="2">Category from the VIM tool</td><td>Phase 1</td><td>Phase 3</td></tr><tr><td>112 patients</td><td>16 patients</td></tr><tr><td>Management—investigations, e.g. fields test</td><td>88% (99)</td><td>100% (16)</td></tr><tr><td>Self-management—importance of taking eyedrops</td><td>83% (... |
45210f9cfd362e4b38cd7911204ffbea489666395199ce40f009e12204ef112e.png | complex | <table><tr><td rowspan="2">Variables</td><td rowspan="2">Coefficient</td><td rowspan="2">Standard error</td><td rowspan="2">p-value</td></tr><tr><td>Course year</td><td>- 0.542</td><td>0.215</td><td>0.015</td></tr><tr><td>Participation in emergency course</td><td>- 0.903</td><td>0.437</td><td>0.044</td></tr></table> |
28d7744a454c39dc00233f16251be8fdda00cc97b8890a0ee5f527e229606f21.png | simple | <table><tr><td>Complication</td><td>Frequencyn</td><td>Percent%</td></tr><tr><td>Present</td><td>73</td><td>44.8</td></tr><tr><td>Absent</td><td>90</td><td>55.2</td></tr><tr><td>Total</td><td>163</td><td>100.0</td></tr></table> |
fed6486013eaafafa528f89fd76d9261c8c4a0292e9b4aec5e70fb81a2cf456d.png | complex | <table><tr><td>Warm-up 1.47 min</td><td>Front leaning stance</td><td>L stance</td></tr><tr><td>Begin with Postural alignment.Shoulders relaxed and in alignment with hips and feet and all facing forward. When standing, feet start shoulder width apart. Repeat each 4 times.</td><td>Step forward one stride length, toes fir... |
d330e5a5950386ed39245b5d85184add58b32ed0d100368724684835f7395741.png | simple | <table><tr><td>miRNA gene</td><td>upstream TATA-box</td><td>ISRE-IRF1 M00972</td><td>IRF1 M00747</td><td>PU.1</td><td>GAS</td><td>IRF3 M00772</td><td>IRF8 M01665</td><td>NF-kappaB M00051</td><td>ETS2 M00340</td><td>Genbank Accesion #</td></tr><tr><td>miR462a/731 cluster</td><td>1</td><td>2</td><td>1</td><td>1</td><td>2... |
09f509466b1e6127403f5b06167b3bab949060bbbc756a01fe509c14e25c57c0.png | simple | <table><tr><td>Groups</td><td>Treatment groups</td><td>Description</td></tr><tr><td>Group I</td><td>Normal control</td><td>Received only diet and water</td></tr><tr><td>Group II</td><td>Vehicle control</td><td>Received water and treated with SRBC</td></tr><tr><td>Group III</td><td>Positive control</td><td>Received Gins... |
78c125a8d7a4ef10af1265b7761fa0f5c604a47706de55ead5ffcd04f4af8fc7.png | complex | <table><tr><td rowspan="2" colspan="2">Branch</td><td rowspan="2">Leading to<sup>a</sup></td><td rowspan="2">#Sets</td><td rowspan="2">#Genes in Sets</td><td colspan="3"># Significant Sets</td></tr><tr><td>Before Pruning</td><td>Without Top Scoring Gene</td><td>After Pruning</td></tr><tr><td>1</td><td>Homininae</td><td... |
2bbad3b4ab5a6c14ed1f6336667e4ebc383391f3ff46a71c2bd41742a2375961.png | simple | <table><tr><td>Gene ID</td><td>Annotation</td><td>FPKM Ctrl</td><td>FPKM -N</td><td>Log<sub>2</sub> FC</td></tr><tr><td>GRMZM2G326707</td><td>Inorganic phosphate transmembrane transporter, PHT1;4</td><td>73.0</td><td>305.5</td><td>2.07</td></tr><tr><td>GRMZM2G154090</td><td>Inorganic phosphate transmembrane transporter... |
63a4e5ecace13671e1ca8d29fc1dfa37a0cda107daf355ef6e9b7639377a89aa.png | simple | <table><tr><td></td><td>Metformin</td><td>Pioglitazone</td><td>Empagliflozin</td><td>Anticipated effect?</td></tr><tr><td>Cardiovascular death</td><td>↓</td><td>↔</td><td>↓↓</td><td>↓↓↓</td></tr><tr><td>All-cause death</td><td>↓</td><td>↔</td><td>↓↓</td>... |
7019fdcb324cfc9ee6ee6619a04a97e1257baac1c382aa5401b2c11e725eb966.png | complex | <table><tr><td colspan="2">Year</td><td>Confirmed positive</td><td>Donor population</td><td>Prevalence by gender</td><td>Total prevalence</td></tr><tr><td rowspan="2">1<sup>st</sup> year</td><td>Male</td><td>124</td><td>80253</td><td>0.15%</td><td rowspan="2">0.18%</td></tr><tr><td>Female</td><td>36</td><td>6524</td><t... |
85ac0e7734658de4f015eb075f92159a63a7b82c7341ddd9bc73db462db82e89.png | complex | <table><tr><td>Variable</td><td>Subgroups</td><td>Number of respondents</td><td>Percentages</td></tr><tr><td rowspan="3">Age (years)</td><td><20</td><td>33</td><td>11.3</td></tr><tr><td>20–25</td><td>221</td><td>75.4</td></tr><tr><td>>25</td><td>39</td><td>13.3</td></tr><tr><td rowspan="3">Age of menarche</... |
73133aaca543672c319c724dec7381d34781a64a4dae6a19967337a1ce51ac16.png | simple | <table><tr><td></td><td>Dyad 1</td><td>Dyad 2</td><td>Dyad 3</td><td>Dyad 4</td><td>Dyad 5</td></tr><tr><td>Mother age</td><td>43</td><td>31</td><td>52</td><td>45</td><td>48</td></tr><tr><td>Youth age</td><td>13</td><td>13</td><td>13</td><td>13</td><td>13</td></tr><tr><td>Youth grade</td><td>8</td><td>8</td><td>8</td><... |
137b506d6abe9c0e529c2708c018d0ae9c22746f9e2fce5ff5ba291d0013daaf.png | complex | <table><tr><td></td><td>Number of responses</td><td>%</td><td>Overall(<i>N</i> Trusts with at least one response/Total N Trusts in region<sup>b</sup>)</td><td>Diabetes(<i>N</i> Trusts with at least one response)</td><td>Cardiac(<i>N</i> Trusts at least one response)</td></tr><tr><td colspan="6">ENGLAND</td></tr><tr><td... |
90290c61a79dd3bdf256e251bd695601946f3fcd54fff01ceae6da913a8087d9.png | simple | <table><tr><td>Primer name</td><td>Sequence</td></tr><tr><td>Notch-1</td><td> </td></tr><tr><td> Forward</td><td>CACTGTGGGCGGGTCC</td></tr><tr><td> Reverse</td><td>GTTGTATTGGTTCGGCACCAT</td></tr><tr><td>Hes1</td><td> </td></tr><tr><td> Forward</td><td>AGCCAACTGAAAACACCTGATT</td></tr><tr><td> Reverse</td><td>GGAGTTTATGA... |
827edb6f2a1fc39bb7fe932d8a5a08489d7245e34b6526be96294ecc24cb8ad1.png | simple | <table><tr><td>Features used</td><td>Attribute type</td></tr><tr><td>Gene Neighborhood score, obtained from STRING</td><td>Real valued, ranges from 0-999</td></tr><tr><td>Gene Fusion score, obtained from STRING</td><td>Real valued, ranges from 0-999</td></tr><tr><td>Gene Co-occurrence score, obtained from STRING</td><t... |
7d60ce5e1171b1dbd4fa4cc027c830b6eeaad23cf7954e6bd501b82f19043882.png | complex | <table><tr><td></td><td>Number of cases</td><td>Gender (%)</td><td>Age median (Range)</td><td>PDAC stage (%)</td></tr><tr><td colspan="5">Cohort 1 (Exploratory phase)</td></tr><tr><td>Healthy</td><td><i>n</i> = 16</td><td>M (62.5)F (37.5)</td><td>59 (54–65)</td><td rowspan="2">Stage IA (16)Stage IIA (24)Stage IIB... |
747134fcefe6dfa6a07ae085f2a637779f4d398a29a17a4f2c2f350c913ea3e1.png | simple | <table><tr><td>Excipient</td><td>Recovery (% ± SD)<sup>(a)</sup></td></tr><tr><td>Starch (50)<sup>(b)</sup></td><td>99.46 ± 0.46</td></tr><tr><td>Glucose (10)</td><td>99.58 ± 1.23</td></tr><tr><td>Lactose (10)</td><td>100.37 ± 0.87</td></tr><tr><td>Acacia (10)</td><td>98.84 ± 0.39</td></tr><tr>... |
1ad7e3f6b7dbba9249d11eade85b5baaa913c1ab98e043b3399ec0dfb04b2dd2.png | simple | <table><tr><td>Haplotypes</td><td>n (%)</td><td>Number of mutated positions</td><td>95% CI</td></tr><tr><td>Single-type(n = 27)</td><td></td><td></td><td></td></tr><tr><td>YEYSNVD</td><td>17 (60.7)</td><td>1</td><td>42.62 - 78.8</td></tr><tr><td>NEFSNVD</td><td>3 (10.7)</td><td>1</td><td>0 - 22.16</td></tr><tr><td>YEFS... |
154243a5097233fc00a0a919eda52901249162f4453058fe903780c742fa17a6.png | complex | <table><tr><td>Characteristics</td><td>Cases (<i>n</i> = 394)</td><td>Controls (<i>n</i> = 794)</td><td><i>p</i> value<sup>a</sup></td></tr><tr><td colspan="4">Marital status (%)</td></tr><tr><td> United<sup>b</sup></td><td>304 (77.2%)</td><td>636 (80.1%)</td><td rowspan="2">0.24</td></tr><tr><td> Not united</td><td>90... |
65f75780de9df9e7c9d934c0dd5943671fcee6bb7021712cfd6b8b4649abc650.png | simple | <table><tr><td>Type of vaginal infections</td><td>Asymptomatic women (<i>N</i> = 261)</td><td>Symptomatic women (<i>N</i> = 148)</td><td><i>P</i>-value</td><td>Pregnant women (<i>N</i> = 214)</td><td>Non-pregnant women (<i>N</i> = 195)</td><td><i>P</i>-value</td><td>Total</td></tr><tr><td>Candidiasis</td><td>24 (9.2)</... |
5b2c723d0b32b148d04c18fcb4af2cfda2af9eafa6410d2a0ed5d91a63528c57.png | complex | <table><tr><td rowspan="2">Variables</td><td colspan="2">KPNA2 expression</td><td rowspan="2"><i>P</i></td></tr><tr><td>Low (<i>N</i> = 23)</td><td>High (<i>N</i> = 80)</td></tr><tr><td>Mean age, y ± SD</td><td>66.9 ± 9.0</td><td>68.5 ± 8.9</td><td>0.513</td></tr><tr><td>Sex, <i>n</i> (%)</td><td></td><t... |
0fadd8febe8ae384769f5306d626e3481f27b9966cc4754be0618a9476895738.png | simple | <table><tr><td>Run no.</td><td>Pretreatment conditions</td><td>H<sub>2</sub>O addition method</td><td>Solid residue (wt%)</td><td>Glucose yield (%)</td><td>Xylose yield (%)</td></tr><tr><td>1</td><td>105°C 6 h</td><td>Aliquot</td><td>34.9</td><td>20.7 ± 0.4</td><td>99.8 ± 2.6</td></tr><tr><td>2<sup>b</su... |
11cd20efc60a947c217c9916e28dd05102c2ba05cf78b545e49b1bf117b347c6.png | simple | <table><tr><td>Variables</td><td>Evaluation instruments</td><td>Quality of instruments</td><td>Time application instruments</td></tr><tr><td>Demographic & obstetric data</td><td>Included in antenatal interview</td><td> </td><td>Antenatal</td></tr><tr><td>Antenatal risk of PPD</td><td>Interview (Riguetti-Veltema &am... |
468621e558d972c63381abd425e8a4977bbf52436d5fd09fe3e833594a50ff16.png | complex | <table><tr><td>Characteristic</td><td>Frequency</td><td>Percentage</td></tr><tr><td colspan="3">Sex</td></tr><tr><td> Male</td><td>372</td><td>62.0</td></tr><tr><td> Female</td><td>228</td><td>38.0</td></tr><tr><td colspan="3">Age category</td></tr><tr><td> 1 (15–35)</td><td>287</td><td>47.8</td></tr><tr><td> 2 (... |
c6890dbbf2e7eafcf45f5b5e8d38a26c290547dfc8b54844d6679c36da1edeeb.png | simple | <table><tr><td>BSI scale</td><td>UK outpatient mean/SD</td><td>Pretreatment score</td><td>Posttreatment score</td></tr><tr><td>PAR</td><td>M = 1.54/SD = 1.08∗</td><td>2.20</td><td>1.50</td></tr><tr><td>ANX</td><td>M = 1.87/SD = 1.03∗</td><td>2.50</td><td>1.60</td></tr></table> |
25e38c0757dcf13e8694434842f075260c2bb844c5a7b5d6a762f4553f3895f4.png | simple | <table><tr><td>Title</td><td>No of species</td><td>Authors</td><td>Reference</td></tr><tr><td>Sporadic study in India</td><td>20</td><td>Gosh A K, Maiti P K</td><td>[44]</td></tr><tr><td>Bhil of Rajasthan</td><td>17</td><td>Sharma S K</td><td>[43]</td></tr><tr><td>Bhil, Gamit, Kokna etc. of Maharastra</td><td>15</td><t... |
dab0b532cce0b4cf833e80737ae229fd1e15a3f0e43a7007917a34326e33d95c.png | simple | <table><tr><td>Material</td><td>Total thermal conductivity (W/m-K)</td><td>LA (%)</td><td>TA (%)</td><td>ZA (%)</td><td>Optical (%)</td></tr><tr><td>Black phosphorene (zigzag)</td><td>110</td><td>32</td><td>22</td><td>31</td><td>15</td></tr><tr><td>Black phosphorene (armchair)</td><td>36</td><td>28</td><td>33</td><td>1... |
fc495986fe02b56e3940a06ef3661b73a26f669633063a2099d380aabacf1bcb.png | simple | <table><tr><td>Parameters</td><td>NGT</td><td>Pre-diabetes</td><td>p value</td></tr><tr><td></td><td>(n = 24)</td><td>(n = 26)</td><td></td></tr><tr><td>Anthropometric measures</td><td></td><td></td><td></td></tr><tr><td>Age (years)</td><td>36 ± 2</td><td>39 ± 2</td><td>0.232</td></tr><tr><td>Weight (Kg)</td>... |
f6524035e484ac4cbc9c77c0ae5d5517effecd86ae4fae167218bcd77dbe9143.png | simple | <table><tr><td>Strain</td><td>Fold-change (light:dark)</td></tr><tr><td>A0047</td><td>1.01 ± 0.38</td></tr><tr><td>A0255</td><td>1.01 ± 0.25</td></tr><tr><td>A0304</td><td>1.29 ± 0.089</td></tr><tr><td>A0318</td><td>1.39 ± 0.34</td></tr><tr><td>A0670</td><td>1.31 ± 0.20</td></tr><tr><td>A0740</... |
bac750b3db8f0b4ad36b8157f5f92cd672a336cb5ef932a68f237ba6521e7112.png | complex | <table><tr><td>Groups</td><td>Compared with groups</td><td>Mean difference (I-J)</td><td>Std. Error</td><td>Sig.</td><td>Lower bound</td><td>Upper bound</td></tr><tr><td rowspan="3">1</td><td>2</td><td>-.80000</td><td>2.49933</td><td>.999</td><td>−8.5278</td><td>6.9278</td></tr><tr><td>3</td><td>4.00000</td><td>2... |
760b7231eb5d26c2807f0c00709ba745b7d2201f5cdcd9b30d31277b1c5b1ff4.png | simple | <table><tr><td></td><td>Case 1</td><td>Case 2</td><td>Case 3</td></tr><tr><td>Age, years</td><td>59</td><td>41</td><td>46</td></tr><tr><td>Sex</td><td>Female</td><td>Female</td><td>Female</td></tr><tr><td>Initial stage</td><td>1A</td><td>ND</td><td>2A</td></tr><tr><td>Histology</td><td>IDC</td><td>IDC</td><td>ILC</td><... |
da3a12b857c73be510b74d79686568c73c664872b8c0096442f57b66ebb9d9e4.png | complex | <table><tr><td> </td><td> </td><td colspan="2">Women</td><td colspan="2">Men</td></tr><tr><td>Months from diagnosis</td><td>Services</td><td>IRR</td><td>95% CI</td><td>IRR</td><td>95% CI</td></tr><tr><td rowspan="3">−12 to −10</td><td>GP</td><td>1.07</td><td>1.06-1.09</td><td>1.13</td><td>1.12-1.15</td></tr... |
d79126e6388e30d6b10d7f162782a2aaeb625cfddf33b64bfafb87b1fb9c89aa.png | complex | <table><tr><td>(A)</td><td>Healthy controls (<i>n</i> = 19)</td><td>ARMS (<i>n</i> = 19)</td><td>First-episode schizophrenia (<i>n</i> = 19)</td><td>Chronic schizophrenia (<i>n</i> = 19)</td><td colspan="2">Group comparison</td></tr><tr><td>Male/female</td><td>9/10</td><td>9/10</td><td>9/10</td><td>9/10</td><td colspan... |
0e14d61bcc123f9d17a3985b78035c78018dd194c7a57d3efce55b8c32c7029d.png | simple | <table><tr><td>Code</td><td>Value</td><td>% Age</td><td>Description</td></tr><tr><td>J</td><td>165</td><td>2.51</td><td>Translation, ribosomal structure and biogenesis</td></tr><tr><td>A</td><td>0</td><td>0.00</td><td>RNA processing and modification</td></tr><tr><td>K</td><td>131</td><td>1.99</td><td>Transcription</td>... |
4c65d06762e002cf6e841aa6827c123a5ec9cdcf46ed357617716a32e1aacc56.png | complex | <table><tr><td rowspan="2">Characteristic</td><td colspan="2">rs3736228</td><td rowspan="2"><i>p</i>-value</td><td colspan="2">rs41494349</td><td rowspan="2"><i>p</i>-value</td><td colspan="2">rs2306862</td><td rowspan="2"><i>p</i>-value</td></tr><tr><td>CC</td><td>CT</td><td>AA</td><td>AG+GG</td><td>CC</td><td>CT+TT</... |
bfd9ea15fe9cf4d5aaf6b7c450cdcb7554572ff863817dc1fa7e753017bae9fd.png | simple | <table><tr><td>Period</td><td>Before education</td><td>First period of education</td><td>Second period of education</td><td>Total</td><td>p-value</td></tr><tr><td>Patients</td><td>276,541</td><td>78,052</td><td>56,950</td><td>411,543</td><td> </td></tr><tr><td>Age (years)</td><td>67.6 ± 17.3</td><td>68.5 ± 17... |
6df0753687285f1e1b813b5890ea06e53018b3dd0aa7953c8e610623bbcb5251.png | simple | <table><tr><td>AA</td><td>Codon</td><td>N</td><td>RSCU</td><td>AA</td><td>Codon</td><td>N</td><td>RSCU</td></tr><tr><td>Ala</td><td>GCU</td><td>10137</td><td>0.61</td><td>Ile</td><td>AUU</td><td>4320</td><td>0.60</td></tr><tr><td></td><td>GCC</td><td>24014</td><td>1.45</td><td></td><td>AUC</td><td>15296</td><td>2.15</t... |
027668a9a29ed5777922572a33337d195dfe9b2a835cf789ecb0558ca94f72a6.png | complex | <table><tr><td>Variable</td><td>EVAM (n = 85)</td><td>OVAM (n = 439)</td><td><i>P</i> value</td></tr><tr><td colspan="4">Demographics</td></tr><tr><td> Age (years, mean ± SD)</td><td>5.6 ± 3.0</td><td>5.3 ± 3.1</td><td>NS</td></tr><tr><td colspan="4">Sex [no. (%)]</td></tr><tr><td> Male</td><td>50 (58.8)... |
90586d05c8611cad3baaf69bba3fdc0d0f42a7529df584c25db109a833e23601.png | complex | <table><tr><td>outcome</td><td>PHFWs</td><td>CHWs</td><td>Total</td><td> P-value</td></tr><tr><td></td><td>Number (%)</td><td>Number (%)</td><td>Number (%)</td><td></td></tr><tr><td>Child recovered</td><td></td><td></td><td></td><td><0.001*</td></tr><tr><td>Yes </td><td>254 (71.7)</td><td>346 (85.2)</td><td>600 (78.... |
4211e18a919b810218a7a29263883d71fe38e811e8b85469f2e3a5cecbd0d2b8.png | complex | <table><tr><td></td><td colspan="2">Mailed questionnaire</td><td colspan="2">Telephone interview</td></tr><tr><td></td><td>%</td><td>N</td><td>%</td><td>N</td></tr><tr><td>Gender</td><td></td><td></td><td></td><td></td></tr><tr><td>Men</td><td>50.5</td><td>1319</td><td>49.0</td><td>681</td></tr><tr><td>Women</td><td>49... |
fdc5aa2497f4307ffcae96f72be36e6c34b6157f385783a3033315797082fbbe.png | complex | <table><tr><td></td><td colspan="3">Type of ringworm</td><td></td></tr><tr><td>Dermatophytes</td><td>Tinea capitisn (%)</td><td>Tinea pedisn (%)</td><td>Tinea corporisn (%)</td><td>Totaln (%)</td></tr><tr><td><i>E. floccosum</i></td><td>0 (0.0)</td><td>1 (9.1)</td><td>0 (0.0)</td><td>1 (2.4)</td></tr><tr><td><i>M. audo... |
c89647bdc36aba6dc5cf0879828bddbf0822c3bcec81fc07d0bd2566670c3761.png | complex | <table><tr><td>SSRs</td><td>Probes used in study</td><td colspan="2">References</td></tr><tr><td></td><td></td><td>Mitotic chromosomes</td><td>Polytene chromosomes</td></tr><tr><td>A</td><td>A<sub>20</sub></td><td></td><td>(21, 40)</td></tr><tr><td>C</td><td>C<sub>20</sub></td><td></td><td>(40)</td></tr><tr><td>AC; AG<... |
ef61a19f279e852f9da201a122247a77037da9e43ff4c88aed4dc734f4bf69d2.png | complex | <table><tr><td></td><td></td><td><i>N</i> = 14 (%)</td></tr><tr><td>Clinical characteristics</td><td></td></tr><tr><td>Age (SAH), years (mean, SD)</td><td></td><td>46.1 ± 12Range: 20–63</td></tr><tr><td>Age (healthy controls), years (mean, SD)</td><td></td><td>47.1 ± 12Range: 20–64</td></tr><tr><t... |
308b3d295b35bd63ba560dcb727878889a9fb7b7702ff3304d8fca39f5e1821f.png | complex | <table><tr><td></td><td colspan="4">Model 1</td><td colspan="4">Model 2</td></tr><tr><td>Variable</td><td><i>B</i></td><td><i>SE</i></td><td>β</td><td><i>t</i></td><td><i>B</i></td><td><i>SE</i></td><td>β</td><td><i>t</i></td></tr><tr><td>Gender</td><td></td><td></td><td></td><td></td><td>–0.408</td><td... |
dc16416b7035dc3176dab664a0b7e5ad15a6291cd3c111be94f7b368661968af.png | complex | <table><tr><td>Location</td><td>Tissue</td><td>Date of collection</td><td>Time period reflected</td><td><i>N</i></td><td><i>N</i> males</td><td><i>N</i> females</td></tr><tr><td rowspan="2">Newfoundland</td><td>Claws</td><td>April 2016</td><td>Winter</td><td>24</td><td>8</td><td>16</td></tr><tr><td>Whole blood</td><td>... |
eb815b8a4d69aea5df6023e110a2666e06cb1ef17f76069cd23af20424e7319f.png | simple | <table><tr><td>Suggestions from COECSA partners</td><td>Suggestions from United Kingdom partners</td></tr><tr><td><i>Program planning and design</i>• There is need for continuous dialog and joint planning• COECSA to drive the process by demonstrating both demand and ownership• More opportunities for v... |
967e843d1347b58b68caa33667f602b04d1fb3461e130937d318e89a60b0a2fe.png | complex | <table><tr><td></td><td colspan="6">BMI (<i>kg</i>/<i>m</i><sup>2</sup>)</td></tr><tr><td></td><td>Overall</td><td>Underweight</td><td>Normal</td><td>Overweight</td><td>Obese I</td><td>Obese II/III</td></tr><tr><td>Males (n = 55,303)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Diabetes melli... |
f6cb25e6ebf6ef0c341fcdd8ed614c7e4e8f39037a835cd51109bb941615ac6c.png | complex | <table><tr><td></td><td>STAV-AB xenograft</td><td>STAV-FCS xenograft</td><td>Localization</td></tr><tr><td colspan="4">MESOTHELIAL AND EPITHELIAL MARKERS</td></tr><tr><td>Calretinin</td><td>++</td><td>++</td><td>Cytoplasm and nucleus</td></tr><tr><td>EMA</td><td>+</td><td>+(+)</td><td>Cell membrane</td></tr><tr><td>E-c... |
decc994da4150d1be12cbfebf8ffcfff3e9034862defee23cef42df2b251ebec.png | complex | <table><tr><td></td><td></td><td>Poorest</td><td>Poorer</td><td>Middle</td><td>Richer</td><td>Richest</td><td>All</td></tr><tr><td rowspan="4">OOP</td><td>Non-chronic</td><td>2287.30</td><td>2550.10</td><td>2854.72</td><td>3057.06</td><td>4013.26</td><td>2952</td></tr><tr><td>Hypertension</td><td>2378.66</td><td>3352.3... |
fc45432ff6b9f8d2368a667af7d598ffe9656c4ab9ab05404dabfa2c886f4f28.png | simple | <table><tr><td>Antibody</td><td>Supplier</td><td>Western dilution</td></tr><tr><td>β-Actin</td><td>Sigma Aldrich</td><td>1 in 3000</td></tr><tr><td>CDK6</td><td>Santa Cruz</td><td>1 in 200</td></tr><tr><td>γH2AX (Ser139)</td><td>Cell Signaling</td><td>1 in 1000</td></tr><tr><td>Lamin a/c</td><td>Santa Cruz</t... |
aec113edb2c1a92e04c56f26cbb98d3e2850360885b2adf8642add4f921399c2.png | complex | <table><tr><td></td><td></td><td></td><td colspan="3">three to five days</td><td colspan="3">17-19 days</td></tr><tr><td>Net</td><td>Family No.</td><td>Species*</td><td>N</td><td>No. Dead</td><td>% Mortality</td><td>N</td><td>No. Dead</td><td>% Mortality</td></tr><tr><td>LLIN#1</td><td>1</td><td>S</td><td>10</td><td>0<... |
d8040b9de7c073f56f96cc3e754b677d80abda40c56ceaacc9fb6d4a63537de1.png | complex | <table><tr><td>Characteristic</td><td>Boys 8 years of age (<i>n</i> = 304)</td><td>Boys 9 years of age (<i>n</i> = 185)</td><td>Total boys (<i>n</i> = 489)</td></tr><tr><td colspan="4">Growth and sexual maturation parameters</td></tr><tr><td>Age [years (mean ± SD)]</td><td>8.04 ± 0.10</td><td>9.02 ± 0.08... |
35c072788bdd1723961143be8a76bd44a478496a39a4665d007b9f9c79e3a8be.png | simple | <table><tr><td>Tocopherol</td><td>Cell type/Cancer model</td><td>Result</td><td>References</td></tr><tr><td>α-Tocopherol</td><td>Human retinal pigment epithelial cells (ARPE-19)</td><td>↑ Nrf2 protein levels, ↑ glutamate cysteine ligase, NQO1, HO-1, GST, SOD</td><td>[90]</td></tr><tr><td>γ-TmT</td... |
dd4d005cab9a0dd24485262640d5ec8cc112c04a2124cfd545a43870119de4f4.png | simple | <table><tr><td>Sample</td><td>Mean ± SD</td></tr><tr><td>Blank</td><td>1.247 ± 0.004</td></tr><tr><td>VC, 0.01 mM (1.7 mg/mL)</td><td>0.045 ± 0.003 *</td></tr><tr><td>BCE, 2.5 μL (875 μg/μL)</td><td>0.668 ± 0.016 *</td></tr><tr><td>BCE, 5 μL (875 μg/μL)</td><td>0.368 &#... |
0b504c31c3f640e225ed5e65c5efb2ea56c81093c6e818261c97ae219e8219fa.png | simple | <table><tr><td> </td><td>CBHI (26)</td><td>Non-CBHI (114)</td><td>t-test</td></tr><tr><td>Population density (per km2)</td><td>184.62</td><td>46.42</td><td>-2.571*</td></tr><tr><td>Poverty rate (%)</td><td>29.6</td><td>40.1</td><td>3.386**</td></tr><tr><td>Literacy rate (%)</td><td>79.00</td><td>64.2</td><td>-4.061**</... |
dd11dd085145bfd88f8fc31118787f11b6560c53f659f845139c9cdcd930a5b2.png | simple | <table><tr><td>Characteristic</td><td>Amiodarone n=20</td><td>Metaprolol n=30</td><td><i>P value</i></td></tr><tr><td>AF%age</td><td>20%</td><td>26.7%</td><td>NS</td></tr><tr><td>Time of Development of AF</td><td>62.15+ 18</td><td>48.4+ 10.2</td><td>NS</td></tr><tr><td>Duration of AF</td><td>12.04+ 10.2</td><td>18.8+ 1... |
f116547cda6c48cb9d34d52f1648acbc2dd2f610012e533710aaf0d1a5cde017.png | simple | <table><tr><td>Characteristics</td><td>Number of patients (%)</td></tr><tr><td>Sex</td><td></td></tr><tr><td>Male</td><td>42 (98)</td></tr><tr><td>Female</td><td>1 (2)</td></tr><tr><td>Age (years)</td><td></td></tr><tr><td>Range</td><td>39–80</td></tr><tr><td>Median</td><td>66</td></tr><tr><td>Stage</td><td></td>... |
89c862a9ef395009d9740724d114bb99bcdfc259cb8a13cb3906f006c4e09fa6.png | complex | <table><tr><td colspan="3">Before the phlebotomy training May 2014</td><td colspan="3">After the phlebotomy training July 2014</td></tr><tr><td>CHC/CDC</td><td>Blood registrations</td><td>Blood rejections <i>n</i> (%)</td><td>Blood registrations</td><td>Blood rejections <i>n</i> (%)</td><td><i>p</i></td></tr><tr><td>A<... |
8cc6ae50dc12b042e30c5928fda156a27a70ba0ce8aff0b72fb57ab3606c2a01.png | simple | <table><tr><td>Subgroup</td><td>No. of datasets</td><td>RR (95% CI)</td><td><i>I</i><sup>2</sup></td><td><i>P</i><sub>heterogeneity</sub></td></tr><tr><td>Total</td><td>7</td><td>1.06 (0.89, 1.26)</td><td>25%</td><td>0.24</td></tr><tr><td>Geographical area</td><td></td><td></td><td></td><td></td></tr><tr><td> North Ame... |
2f7aa2f9a8289303fb8d00a9269cf26b016de08273e52f99266c0d1ea853ba7a.png | complex | <table><tr><td></td><td>K</td><td>AIC</td><td>ΔAICc</td><td>wi</td></tr><tr><td colspan="5">All species</td></tr><tr><td> Distance to road</td><td>2</td><td>2401.35</td><td>0</td><td>0.78</td></tr><tr><td> Constant survival</td><td>1</td><td>2405.17</td><td>3.82</td><td>0.11</td></tr><tr><td> Distance to edge</td>... |
b4cd3a4bff1213707ba132ebf85804b07c7011591b0f2ef74e6d50af37f21a83.png | complex | <table><tr><td rowspan="2">Characteristics</td><td>CMV infection</td><td>No CMV infection</td><td rowspan="2">p</td></tr><tr><td><i>N</i> = 21</td><td><i>N</i> = 65</td></tr><tr><td>Age, mean ± SD, y</td><td>51.4 ± 13.8</td><td>46.8 ± 15.6</td><td>0.244</td></tr><tr><td>Gender, male (%)</td><td>57.1</td>... |
8c0d539b86da4c1596462b60a57fd48e652a9c31f075abd7a2d5d22955d37515.png | complex | <table><tr><td>Characteristic</td><td>Total Group (<i>n</i> = 270)</td><td>IR (<i>n</i> = 183)</td><td>ID/IDA (<i>n</i> = 87)</td><td><i>p</i>-Value <sup>1</sup></td></tr><tr><td>Age (years)</td><td>25.9 ± 5.0</td><td>26.3 ± 4.9</td><td>25.3 ± 5.2</td><td>0.131</td></tr><tr><td>Highest Educational Attain... |
2eac6cb73cf919098b0ba55d7439015c6903e4febe9e664af6d823a182e7488b.png | simple | <table><tr><td></td><td>Gene name</td><td>Gene Accession number</td><td>Score (d)</td><td>Log<sub>2 </sub>expression ratio</td></tr><tr><td>Genes mainly expressed in skeletal muscle</td><td>Nebulette (Actin-binding Z-disk protein)</td><td>NM_006393</td><td>42.93</td><td>3.81</td></tr><tr><td></td><td>Troponin I, fast s... |
fc58b38499cd6e987e8b8f7083561daa3660c820e9140e8742402c661ce5b046.png | simple | <table><tr><td>Gene ID<sup>a</sup></td><td>Primers (5′-3′)</td><td>Accession No.</td><td>Amplicon length</td></tr><tr><td><i>Act- β</i></td><td>Forward: CGGCATCGAGGACAGGATReverse: CATCGTACTCCTGCTTGCTGAT</td><td>NM_173979.3</td><td>169</td></tr><tr><td><i>GAPDH</i></td><td>Forward: CCTGCCCGTTCGACAGATARe... |
f47fe9fbf6eb0dddbe4dc76e2d0c8760c8f2824b14f92e28f1ea3322eaa9b1bb.png | complex | <table><tr><td rowspan="2">Characteristic/subcategory</td><td colspan="3">Discomfort of acupuncture: No. (%)</td><td colspan="2">No discomfort<sup>a</sup></td><td colspan="2">Slight discomfort<sup>a</sup></td></tr><tr><td>No</td><td>Slight</td><td>Moderate to severe</td><td>OR (95% CI)</td><td><i>P</i> value</td><td>OR... |
47a22320ac4d1e6a0e386dc0b45162385b9ef4607beee2de69be7d30466df77e.png | complex | <table><tr><td rowspan="2">Characteristics</td><td rowspan="2">Category</td><td colspan="2">NSSIs</td><td rowspan="2">p-value</td></tr><tr><td>Present</td><td>Absent</td></tr><tr><td>Faculty</td><td>MBBS</td><td>18 (64.3)</td><td>10 (35.7)</td><td></td></tr><tr><td></td><td>BDS</td><td>9 (56.3)</td><td>7 (43.8)</td><td... |
6e00717f57a2ce0cb9b5acc8e91f757f0de250296db88ce6b72596540616be71.png | complex | <table><tr><td>Item</td><td>Descriptions</td></tr><tr><td>Number of stations</td><td>12</td></tr><tr><td>Date span </td><td>1–30 May 2015; 1–30 July 2016</td></tr><tr><td>Signal selection</td><td>GPS: L1/L2/L5; GLONASS: L1/L2; BeiDou: B1/B2/B3; Galileo: E1/E5a/E5b</td></tr><tr><td>Sampling interval</td><td>... |
5208217a0cf4440035ef28e260176bdda86ffd7d1ee3fe71093e9aafaa0bddd5.png | complex | <table><tr><td rowspan="2">Ethnic group</td><td colspan="3"><i>α</i>-globin genotypes</td><td>Total</td></tr><tr><td>- -<i>α</i><sup>3.7</sup>/<i>αα</i></td><td>- -<i>α</i><sup>4.2</sup>/<i>αα</i></td><td>- -<sup>SEA</sup>/<i>αα</i></td></tr><tr><td>Malay (<i>n</i> = 315)</t... |
ece74e5f526bffcf8d87170862cfdc1699804123fa29822068e81f06b49bdf91.png | complex | <table><tr><td>Strain</td><td><i>D</i></td><td><i>Y</i><sub><i>xs</i></sub></td><td>r<sub>s</sub></td><td>r<sub>CO2</sub></td><td>r<sub>O2</sub></td><td>r<sub>etoh</sub></td><td>r<sub>acet</sub></td><td>RQ</td><td>C<sub>s</sub></td><td>C<sub>balance</sub></td><td>Tot<sub>sant</sub></td></tr><tr><td> </td><td>(h<sup>-1<... |
88346badf41ed8c653c7b679715cc8ac34a4fc79c023ac080be59a2358f6723b.png | complex | <table><tr><td>PPI Dataset</td><td>Methods</td><td>Precision</td><td>Recall</td><td><i>F</i>-score</td><td>Sn</td><td>PPV</td><td>Accuracy</td></tr><tr><td rowspan="10">DIP</td><td>CDUN</td><td>0.6</td><td>0.551</td><td>0.575</td><td>0.431</td><td>0.641</td><td>0.526</td></tr><tr><td>CSO</td><td>0.497</td><td>0.623</td... |
287ea07aaade575b9758e32c25ce34f7c3c4200a8d1e81e70cfc6858630b5c3d.png | simple | <table><tr><td></td><td><i>M</i></td><td>SD</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td><td>9</td></tr><tr><td>Threat appraisal</td><td>54.34</td><td>14.84</td><td></td><td>0.00</td><td>0.27*</td><td>0.14</td><td>0.05</td><td>−0.32*</td><td>−0.27*</td><td>−0.08<... |
0d608731d643f4c0e17b447a7372c1e3ce858447d6131c08eacf862f6191d57b.png | simple | <table><tr><td>Species Name</td><td>LC50/EC50 (95% Confidence Interval Limit)</td><td>Study</td></tr><tr><td><i>Oreochromis niloticus</i></td><td>3760 mg∙L<sup>−1</sup> (2990–4010)</td><td>Omoregie et al. (2009) [39]</td></tr><tr><td><i>Chironomus yoshimatsui</i></td><td>1520 mg∙L<sup>−1</... |
3cd5aad1750eccc665bb8196a0b256e5853e3a199533320e52950c281c91ddc1.png | complex | <table><tr><td rowspan="3"></td><td colspan="5">0.033 mg/kg/day</td><td colspan="5">0.067 mg/kg/day</td></tr><tr><td rowspan="2">Total</td><td rowspan="2">Glucose intolerant type</td><td colspan="3">Time point evaluated as the glucose intolerant type</td><td rowspan="2">Total</td><td rowspan="2">Glucose intolerant type... |
699624555de8a0c9d0f986d43daeb22cb474764421dd6d845e7ead5906770bdb.png | simple | <table><tr><td></td><td>2010 audit<i>n</i> = 82</td><td>2011 re-audit<i>n</i> = 140</td></tr><tr><td>Patients who had at least one neuroimaging procedure (through MAS or previous), <i>n</i> (%)</td><td>56 (68)</td><td>106 (76)</td></tr><tr><td>Neuroimaging requested through MAS, <i>n</i> (%)</td><td>48 (59)</td><td>88 ... |
3e32bf3bc6ace359013f5f347f92efa37b2cdbab0168123d5778fb5b0dcfa0e3.png | simple | <table><tr><td> VA outcome</td><td>Fox (<i>n</i> = 19)</td><td>Clark (<i>n</i> = 36)</td><td>Al-Mezaine (<i>n</i> = 17)</td><td>Shirodkar (<i>n</i> = 26)</td><td>Overall (<i>n</i> = 98)</td></tr><tr><td>≥20/40</td><td>9 (47.3%)</td><td>18 (50%)</td><td>5 (29.4%)</td><td>13 (50%)</td><td>45 (45.9%)</td></tr><tr><t... |
baa80ddbc7e465c87aeb531eb30f4022acc001723396e2f4c6ea0d91bc78a585.png | simple | <table><tr><td>Parameter</td><td>Definition</td></tr><tr><td><i>N</i></td><td>Number of individuals in the population</td></tr><tr><td><i>Z</i></td><td>Probability to reproduce by self-fertilization</td></tr><tr><td><i>w</i></td><td>Fitness of an individual</td></tr><tr><td><i>n</i></td><td>Number of TE copies in the g... |
6bd895bf47a58dd5df7c3566de7a8e68a34fcf868f004eb4a944fe6021d28473.png | complex | <table><tr><td rowspan="2">Gene list</td><td rowspan="2"><i>N</i> genes</td><td colspan="2">Proportion of genome</td><td colspan="2">SNP heritability (<i>P</i> value)</td></tr><tr><td>SNPs</td><td>Mb</td><td>All samples</td><td>Infliximab+Adalimumab</td></tr><tr><td>Whole genome</td><td>—</td><td>1</td><td>1</td>... |
44213c275d4d96ebbfe657bb946107affc0d04a10b30eecfa2a4fee8ef747bb7.png | simple | <table><tr><td>Sample</td><td>[M]/[I]</td><td>m<sub>M</sub>, g</td><td>m<sub>C</sub>, mg</td></tr><tr><td>MWS-1 MWS-2 MWS-3</td><td>1/1,000</td><td>5</td><td>14.05</td></tr><tr><td>MWS-4 MWS-5 MWS-6</td><td>1/5,000</td><td>5</td><td>2.81</td></tr><tr><td>MWS-7 MWS-8 MWS-9</td><td>1/10,000</td><td>5</td><td>1.41</td></t... |
c277c51f747cd593c8f41af26f2ed557b01005d51a81e8a7ada3981b25019a19.png | simple | <table><tr><td>Human protein</td><td>Targeting DNA virus families</td><td>Targeting RNA virus families</td></tr><tr><td>HNRPK – heterogeneous nuclear ribonucleoprotein K</td><td>Asfarviridae, Herpesviridae, Papillomaviridae, Poxviridae</td><td>Arteriviridae, Filoviridae, Flaviviridae, Orthomyxoviridae, Paramyxovi... |
c13f629e5b430c86f1357ec7ce14ba712f151a43347baed668f33391701d12db.png | simple | <table><tr><td>Stage of Lactation (Month)</td><td>2</td><td>5</td><td>9</td><td>12</td></tr><tr><td>Maternal age (years)</td><td>32.9 ± 4.21 (28–40)</td><td>33.4 ± 4.27 (24–40)</td><td>34.0 ± 4.57 (25–43)</td><td>34.1 ± 4.35 (26–44)</td></tr><tr><td>Maternal BMI</td><td>27.1 ... |
ea4e261ee1223fe99ca8478bcc4abe5548b993b1b04ed09891db77ad2bd2cd94.png | simple | <table><tr><td>Group</td><td><i>E</i><sub>1</sub>′ (MPa)</td><td><i>E</i><sub>2</sub>′ (MPa)</td><td><i>t<sub>s</sub></i> (min)</td><td><i>G</i><sub>∞</sub></td><td><i>R</i><sup>2</sup></td></tr><tr><td>L65</td><td>10.1408 ± 5.8173</td><td>16.4475 ± 5.8594</td><td>0.6501 ± 0.1888</td><t... |
d190e1141ad8cca78d53b58df7f1c57cfce82fcae54db22fbae1ff71b09548f3.png | complex | <table><tr><td rowspan="2" colspan="2">Characteristics</td><td rowspan="2">Yes <i>n</i> (%)</td><td colspan="3">Non-compliance to HPV vaccination</td></tr><tr><td>Prevalence</td><td><i>p</i> value</td><td>Odds Ratio (CI 95 %)</td></tr><tr><td rowspan="2">Parent’s religion</td><td>Protestant</td><td>262 (44,1 %)</... |
9e895e56080131bdb7cd0c964d77a55d7a9bf7cb7f4c4632d949d186d9e07b14.png | complex | <table><tr><td>Population</td><td>IDF guideline recommendation</td><td>Assessment in study</td></tr><tr><td>All acne patients</td><td>Assign treatment according to acne severity</td><td>Not assessed in study: could not be evaluated by computerized query (Disease severity not stated within diagnosis field)</td></tr><tr>... |
4c2e55aa7ded48d4d5452fb0c4e26b6a092d76f9f66d87e85a92f5cade747c4b.png | simple | <table><tr><td>Characteristic</td><td>No. of patients</td><td>%</td></tr><tr><td>Patients evaluable</td><td>70</td><td>100</td></tr><tr><td>Age, years</td><td> </td><td> </td></tr><tr><td> Median (range)</td><td>65 (32–75)</td><td> </td></tr><tr><td>Sex</td><td> </td><td> </td></tr><tr><td> Male</td><td>41</td><t... |
99f9a631ead7412b09e0504a0bd9b1fc40d42fd74e693e3b86df037a7d218204.png | simple | <table><tr><td> </td><td>1995</td><td>1996</td><td>1997</td><td>1998</td><td>1999</td><td>2000</td><td>2001</td><td>2002</td><td>2003</td><td>2004</td><td>2005</td><td>2006</td><td>2007</td><td>2008</td><td>2009</td><td>2010</td><td>2011</td><td>Sum</td><td>%</td></tr><tr><td>jan</td><td> </td><td> </td><td> </td><td> ... |
ce8cb00dc3be216bae94abdec50453a878b5c15414a982fb63f2832b1531349b.png | complex | <table><tr><td></td><td>Lipid emulsion (n = 16)</td><td>Control (n = 11)</td></tr><tr><td>Initiation of enteral nutrition (h)</td><td>10.63 ± 5.49</td><td>9.27 ± 6.69</td></tr><tr><td>Age at feeds >100 mL/kg per day (days)</td><td>11.69 ± 4.75</td><td>7.55 ± 3.77*</td></tr><tr><td>Period of paren... |
b8c8a05ec61d775e5b2f72d5462549fa06c2a38b48d359d2b71a602a1f243fb4.png | complex | <table><tr><td rowspan="2">Indicator</td><td colspan="2">Participants<sup>a</sup></td><td rowspan="2"><i>P</i></td></tr><tr><td>With probable depression at baseline(<i>n</i> = 309)</td><td>Without probable depression at baseline(<i>n</i> = 266)</td></tr><tr><td>Treatment outcome, no. (%)</td><td></td><td></td><td></td>... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.